Causes and determinants of mortality in HIV-infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trial

Hdl Handle:
http://hdl.handle.net/10144/337112
Title:
Causes and determinants of mortality in HIV-infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trial
Authors:
Marcy, Olivier; Laureillard, Didier; Madec, Yoann; Chan, Sarin; Mayaud, Charles; Borand, Laurence; Prak, Narom; Kim, Chindamony; Lak, Kim Khemarin; Hak, Chanroeurn; Dim, Bunnet; Sok, Thim; Delfraissy, Jean-François; Goldfeld, Anne E; Blanc, François-Xavier
Journal:
Clinical Infectious Diseases : an official publication of the Infectious Diseases Society of America
Abstract:
Shortening the interval between antituberculosis treatment onset and initiation of antiretroviral therapy (ART) reduces mortality in severely immunocompromised human immunodeficiency virus (HIV)-infected patients with tuberculosis. A better understanding of causes and determinants of death may lead to new strategies to further enhance survival.
Publisher:
Oxford University Press
Issue Date:
Aug-2014
URI:
http://hdl.handle.net/10144/337112
DOI:
10.1093/cid/ciu283
PubMed ID:
24759827
Language:
en
ISSN:
1537-6591
Appears in Collections:
HIV/AIDS

Full metadata record

DC FieldValue Language
dc.contributor.authorMarcy, Olivieren_GB
dc.contributor.authorLaureillard, Didieren_GB
dc.contributor.authorMadec, Yoannen_GB
dc.contributor.authorChan, Sarinen_GB
dc.contributor.authorMayaud, Charlesen_GB
dc.contributor.authorBorand, Laurenceen_GB
dc.contributor.authorPrak, Naromen_GB
dc.contributor.authorKim, Chindamonyen_GB
dc.contributor.authorLak, Kim Khemarinen_GB
dc.contributor.authorHak, Chanroeurnen_GB
dc.contributor.authorDim, Bunneten_GB
dc.contributor.authorSok, Thimen_GB
dc.contributor.authorDelfraissy, Jean-Françoisen_GB
dc.contributor.authorGoldfeld, Anne Een_GB
dc.contributor.authorBlanc, François-Xavieren_GB
dc.date.accessioned2014-12-11T22:47:59Z-
dc.date.available2014-12-11T22:47:59Z-
dc.date.issued2014-08-
dc.identifier.citationCauses and determinants of mortality in HIV-infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trial. 2014, 59 (3):435-45 Clin. Infect. Dis.en_GB
dc.identifier.issn1537-6591-
dc.identifier.pmid24759827-
dc.identifier.doi10.1093/cid/ciu283-
dc.identifier.urihttp://hdl.handle.net/10144/337112-
dc.description.abstractShortening the interval between antituberculosis treatment onset and initiation of antiretroviral therapy (ART) reduces mortality in severely immunocompromised human immunodeficiency virus (HIV)-infected patients with tuberculosis. A better understanding of causes and determinants of death may lead to new strategies to further enhance survival.en_GB
dc.language.isoenen
dc.publisherOxford University Pressen_GB
dc.rightsArchived on this site with kind permission of Oxford University Press and thanks to Clinical Infectious Diseases : an official publication of the Infectious Diseases Society of Americaen_GB
dc.titleCauses and determinants of mortality in HIV-infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trialen
dc.identifier.journalClinical Infectious Diseases : an official publication of the Infectious Diseases Society of Americaen_GB

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.